Background & Aims: Hepatitis B virus (HBV) persistence and the pathobiology of chronic HBV (CHB) infections result from the interplay between viral replication and host immune responses. We aimed to comprehensively analyse the expression of intrahepatic host genes as well as serum and liver HBV markers in a large cohort of untreated CHB patients. Methods: One-hundred and five CHB patients untreated at the time of liver biopsy (34 HBeAg[+] and 71 HBeAg[-]) were analysed for the intrahepatic expression profile of 67 genes belonging to multiple innate immunity pathways. Results were correlated to serological (quantification of HBsAg [qHBsAg] and HBV DNA) and intrahepatic viral markers (total HBV DNA, pre-genomic RNA and covalently closed circular HBV DNA). Results: Intrahepatic gene expression profiling revealed a strong downregulation of antiviral effectors, interferon stimulated genes, Toll-like and pathogen recognition receptor pathways in CHB patients as compared to non-infected controls, which was not directly correlated to HBV replication. A subset of genes [CXCL10, GBP1, IFITM1, IFNB1, IL10, IL6, ISG15, TLR3, SOCS1, SOCS3] was more repressed in HBeAg(-) respect to HBeAg(+) patients (median of serum HBV DNA 7.9 +/- 10^3 vs. 7.9 +/- 10^7 IU/ml, respectively). Notably, HBeAg(-) patients with lower qHBsAg (<5 x 10^3 IU/ml) showed a relief of repression of genes belonging to multiple pathways. Conclusions: Our results show a strong impairment of innate immune responses in the liver of CHB patients. The association of low levels of qHBsAg with gene repression, if confirmed, might prove useful for the identification of patients who would most benefit from immune-modulators and/or HBsAg targeting agents as strategies to restore immune responsiveness.

Intrahepatic innate immune response pathways are downregulated in untreated chronic hepatitis B patients / Lebossé, Fanny; Testoni, Barbara; Fresquet, Judith; Facchetti, Floriana; Galmozzi, Enrico; Fournier, Maëlenn; Hervieu, Valérie; Berthillon, Pascale; Berby, Françoise; Bordes, Isabelle; Durantel, David; Levrero, Massimo; Lampertico, Pietro; Zoulim, Fabien. - In: JOURNAL OF HEPATOLOGY. - ISSN 0168-8278. - 66:5(2017), pp. 897-909. [10.1016/j.jhep.2016.12.024]

Intrahepatic innate immune response pathways are downregulated in untreated chronic hepatitis B patients

LEVRERO, Massimo;
2017

Abstract

Background & Aims: Hepatitis B virus (HBV) persistence and the pathobiology of chronic HBV (CHB) infections result from the interplay between viral replication and host immune responses. We aimed to comprehensively analyse the expression of intrahepatic host genes as well as serum and liver HBV markers in a large cohort of untreated CHB patients. Methods: One-hundred and five CHB patients untreated at the time of liver biopsy (34 HBeAg[+] and 71 HBeAg[-]) were analysed for the intrahepatic expression profile of 67 genes belonging to multiple innate immunity pathways. Results were correlated to serological (quantification of HBsAg [qHBsAg] and HBV DNA) and intrahepatic viral markers (total HBV DNA, pre-genomic RNA and covalently closed circular HBV DNA). Results: Intrahepatic gene expression profiling revealed a strong downregulation of antiviral effectors, interferon stimulated genes, Toll-like and pathogen recognition receptor pathways in CHB patients as compared to non-infected controls, which was not directly correlated to HBV replication. A subset of genes [CXCL10, GBP1, IFITM1, IFNB1, IL10, IL6, ISG15, TLR3, SOCS1, SOCS3] was more repressed in HBeAg(-) respect to HBeAg(+) patients (median of serum HBV DNA 7.9 +/- 10^3 vs. 7.9 +/- 10^7 IU/ml, respectively). Notably, HBeAg(-) patients with lower qHBsAg (<5 x 10^3 IU/ml) showed a relief of repression of genes belonging to multiple pathways. Conclusions: Our results show a strong impairment of innate immune responses in the liver of CHB patients. The association of low levels of qHBsAg with gene repression, if confirmed, might prove useful for the identification of patients who would most benefit from immune-modulators and/or HBsAg targeting agents as strategies to restore immune responsiveness.
2017
cccDNA; HBsAg; HBV; intrahepatic innate immune response; hepatology
01 Pubblicazione su rivista::01a Articolo in rivista
Intrahepatic innate immune response pathways are downregulated in untreated chronic hepatitis B patients / Lebossé, Fanny; Testoni, Barbara; Fresquet, Judith; Facchetti, Floriana; Galmozzi, Enrico; Fournier, Maëlenn; Hervieu, Valérie; Berthillon, Pascale; Berby, Françoise; Bordes, Isabelle; Durantel, David; Levrero, Massimo; Lampertico, Pietro; Zoulim, Fabien. - In: JOURNAL OF HEPATOLOGY. - ISSN 0168-8278. - 66:5(2017), pp. 897-909. [10.1016/j.jhep.2016.12.024]
File allegati a questo prodotto
File Dimensione Formato  
Lebossè_Intrahepatic_2017.pdf

solo gestori archivio

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 1.87 MB
Formato Adobe PDF
1.87 MB Adobe PDF   Contatta l'autore

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/937115
Citazioni
  • ???jsp.display-item.citation.pmc??? 45
  • Scopus 118
  • ???jsp.display-item.citation.isi??? 107
social impact